In this 15th episode of the Digitalization Tech talks hosted by Jonas Norinder and Don Mack, we’ll take a deep dive into the burgeoning field of cell & gene therapy, which promises individualized therapeutics that will essentially be manufactured to the specifications of a single patient. We’ll also discuss how digitalization techniques can be applied to accelerate time to market and connect the entire value chain. Joining us in this episode is our guest, Austin Little who is an Industry Manager for cell & gene therapy for Siemens. Austin will talk about topics ranging from an overview of the trends that drive the gene & cell therapy market along with challenges that need to be overcome in the manufacturing space, go to market strategies and much more.Show notesWebsite: American Society of Gene & Cell Therapy | ASGCTWebsite: Digitized production for personalized medicineVideo: Individualized production in PharmaVideo: LivingLab - testing visionary ideas in real lifeVideo: Paperless manufacturingWebsite: Siemens pharmaContact us at:Austin Little (austin.little@siemens.com)Jonas Norinder (jonas.norinder@siemens.com)Don Mack (mack.donald@siemens.com)